CMR In the 2021 AHA / ACC / ASE / CHEST / SAEM / SCCT / SCMR Guideline for the Evaluation and Diagnosis of Chest Pain< Back To Feed
Evidence supports that CMR can identify wall motion abnormalities and myocardial edema, and distinguish infarct-related scar from non-CAD causes such as myocarditis and nonischemic cardiomyopathy.
The 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain has officially been released, and we were pleased to see that cardiovascular magnetic resonance imaging (CMR) has been well represented with Class 1 or Class 2a recommendations for CMR in all clinical scenarios. The recently published guideline demonstrates that CMR is now considered at least equivalent to other cardiovascular imaging methods. For example, stress CMR is now one of the recommended options (in addition to stress echocardiography, stress PET or stress SPECT) for patients with suspected ACS at intermediate risk with acute chest pain and known CAD. In addition, CMR can help evaluate non-ischemic causes for acute chest pain, for example in troponin-positive cases with absence of obstructive CAD.
Our structured reporting tool, cardioDI, can help you generate high-quality, data-driven CMR reports for many of the diagnostic scenarios outlined in the 2021 chest pain guideline, including features like graphical scoring for stress, edema, function, and fibrosis. You can also link clinical indications to guideline-recommended imaging protocols within cardioDI’s exam planning tool, saving you time and standardizing your imaging workflow.
To learn more about the 2021 chest pain guidelines, please refer to the SCMR or ACC websites. To learn more about how Cohesic’s Decision Intelligence approach to structured reporting can enhance your clinical practice, check out our cardioDI modules for CMR and CCT.
Want to stay up to date on the latest news in Cardiac Imaging? Subscribe to our newsletter below or reach out to us directly!